La-med Healthcare eyes revenues of over Rs 100 crore by 2021

Expanding footprints to South America, Peru, Australia and Mexico

267
La-med Healthcare
Mayank Lakhani, managing director at La-med Healthcare

La-med Healthcare, a leading manufacturer and marketer of premium, single-use medical devices, has recently announced that it is on track to achieve revenues of over Rs 100 crore in 2021 fiscal. The company is all set to enter new and untapped global markets, including South America, Australia, New Zealand, South America, Peru, Chile, Panama, and Mexico.

The Faridabad-based company currently has a strong domestic as well as global distribution network, manufacturing, and supplying affordable premium quality medical devices such as needle-free connectors, ventilator Circuits with combo kits, PTCA kits and anti UV extension lines across pan-India and 55 countries across the globe. The company has adopted ISO 9001:2015 quality management system and ISO 13485:2016 Quality management system, especially for medical devices. All La-Med products have a CE-marking from DNV GL PRESAFE Norway, a certification body, making it a trusted quality manufacturer of medical devices in major government hospitals and institutions pan India and the world. La-Med has a manufacturing plant in Faridabad, Haryana.

Commenting on this, Mayank Lakhani, managing director of La-med Healthcare, said, “We clocked revenue of Rs 20.5 crores in the last quarter and are on our way to achieve our target Rs 100 crore revenue for the FY 2021 on the back of organic as well as inorganic expansion. In the coming years, our products will be available in new global territories that are currently untapped but have huge potential for a company like ours. We are also reviving up our manufacturing potential and are in the process of constructing another plant parallel to the existing plant by December 2020. We are optimistic that 2020 will be a conducive year for growth at La-Med.”

In addition to expanding its geographical reach around the world, the company also plans to introduce new and innovative products with the underlying principle of safety to facilitate better patient care. Six Sigma process controls and top quality management (TQM) measures have been built into all La-Med processes.

The Covid-19 pandemic led to the country-wide lockdown on 25 March 2020. It will be two years tomorrow as I write this. What have we learned in this time? Maybe the meaning of resilience since small companies like us have had to rely on our resources and the forbearance of our employees as we have struggled to produce our trade platforms.

The print and packaging industries have been fortunate, although the commercial printing industry is still to recover. We have learned more about the digital transformation that affects commercial printing and packaging. Ultimately digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is a leapfrog technology that will only increase the demand for print in the foreseeable future.

Web analytics show that we now have readership in North America and Europe amongst the 90 countries where our five platforms reach. Our traffic which more than doubled in 2020, has at times gone up by another 50% in 2021. And advertising which had fallen to pieces in 2020 and 2021, has started its return since January 2022.

As the economy approaches real growth with unevenness and shortages a given, we are looking forward to the PrintPack India exhibition in Greater Noida. We are again appointed to produce the Show Daily on all five days of the show from 26 to 30 May 2022.

It is the right time to support our high-impact reporting and authoritative and technical information with some of the best correspondents in the industry. Readers can power Packaging South Asia’s balanced industry journalism and help sustain us by subscribing.

– Naresh Khanna

Subscribe Now

LEAVE A REPLY

Please enter your comment!
Please enter your name here